Fresenius Medical Care (FMS) Financials

$29.51 +0.49 (+1.69%)

Closing price 05/27/2025 03:59 PM Eastern

Extended Trading

$29.25 -0.26 (-0.88%)

As of 04:19 AM Eastern

Annual Income Statements for Fresenius Medical Care

This table shows Fresenius Medical Care's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Income / (Loss) Attributable to Common Shareholders	557	552	720	1,097	1,422	1,346	2,268	1,537	1,203	1,315	1,045
Consolidated Net Income / (Loss)	767	810	957	1,380	1,754	1,614	2,547	1,867	1,494	1,315	1,260
Net Income / (Loss) Continuing Operations	767	810	957	1,380	1,754	1,614	2,547	1,867	1,223	1,315	1,513
Total Pre-Tax Income	1,094	1,143	1,304	1,779	2,366	2,065	3,132	2,400	2,152	1,929	1,843
Total Operating Income	1,441	1,515	1,388	2,096	2,815	2,547	2,467	2,726	2,534	2,282	2,255
Total Gross Profit	4,924	5,448	4,436	5,402	6,765	6,056	5,900	7,229	5,908	5,625	4,996
Total Revenue	20,015	21,520	20,752	19,941	21,817	19,613	18,938	21,362	17,431	16,792	16,134
Operating Revenue	20,015	21,520	20,752	19,941	21,817	19,613	18,938	21,362	17,431	16,792	16,134
Total Cost of Revenue	15,091	16,072	16,316	14,539	15,052	13,558	13,038	14,133	11,523	11,167	10,836
Total Operating Expenses	4,409	4,638	3,048	4,053	4,065	3,591	3,433	4,503	3,450	3,343	2,791
Selling, General & Admin Expense	4,219	4,381	3,392	3,803	3,828	3,403	3,302	4,370	3,296	3,204	2,644
Research & Development Expense	190	257	245	250	237	189	131	133	154	139	122
Total Other Income / (Expense), net	579	333	-83	430	-334	-399	665	-327	-577	-353	-411
Interest & Investment Income	74	98	72	83	51	69	169	62	-67	114	84
Other Income / (Expense), net	505	235	230	347	-385	-468	1,010	112	-511	31	-
Income Tax Expense	327	332	348	399	611	451	585	532	658	614	584
Net Income / (Loss) Attributable to Noncontrolling Interest	-210	-258	-236	-283	-332	-268	-279	-330	-290	-	215
Basic Earnings per Share	$1.89	$1.88	$2.46	$3.31	$3.96	$3.96	$6.47	$4.17	$3.74	$3.14	$3.46
Weighted Average Basic Shares Outstanding	293.41M	293.41M	293.41M	293.00M	292.88M	298.33M	298.33M	306.45M	306.22M	305.31M	306.45M
Diluted Earnings per Share	$1.89	$1.88	$2.46	$3.31	$3.96	$3.96	$6.45	$4.16	$3.73	$3.13	-
Weighted Average Diluted Shares Outstanding	293.41M	293.41M	293.41M	293.00M	292.88M	298.33M	298.33M	306.45M	306.22M	305.31M	306.45M
Weighted Average Basic & Diluted Shares Outstanding	293.41M	293.41M	293.41M	293.00M	292.88M	298.33M	298.33M	306.45M	306.22M	305.31M	306.45M

No quarterly income statements for Fresenius Medical Care are available.

This table details how cash moves in and out of Fresenius Medical Care's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Change in Cash & Equivalents	2,162	1,625	1,886	2,981	3,860	-1,277	1,336	2,366	4,864	2,387	4,263
Net Cash From Operating Activities	2,170	2,174	2,060	2,428	5,208	3,786	2,360	2,795	2,831	2,708	1,861
Net Cash From Continuing Operating Activities	2,170	2,174	2,060	2,428	5,208	3,786	2,629	2,795	2,831	2,708	2,364
Net Income / (Loss) Continuing Operations	767	810	957	1,380	1,754	1,614	2,547	1,867	1,494	1,315	1,260
Consolidated Net Income / (Loss)	767	810	957	1,380	1,754	1,614	2,547	1,867	1,494	1,315	1,260
Depreciation Expense	1,803	1,938	1,967	1,838	2,182	1,788	904	883	738	704	699
Non-Cash Adjustments To Reconcile Net Income	-534	-571	-446	-432	-562	768	-657	21	234	-150	-2.65
Changes in Operating Assets and Liabilities, net	134	-3.06	-417	-358	1,834	-384	-165	23	365	838	408
Net Cash From Investing Activities	-96	-606	-773	-1,458	-1,601	-4,447	280	-680	549	-310	-2,691
Net Cash From Continuing Investing Activities	-96	-606	-773	-1,458	-1,601	-4,447	-315	-680	549	-310	867
Purchase of Property, Plant & Equipment	-724	-757	-775	-967	-1,285	-1,262	-	-	-	-	-932
Acquisitions	-24	-39	-63	-491	-316	-2,493	-	-680	549	-310	1,779
Divestitures	652	190	64	-	-	49	-	-	-	-	8.26
Net Cash From Financing Activities	88	57	599	2,012	254	-274	780	251	1,484	-12	805
Net Cash From Continuing Financing Activities	88	57	599	2,012	254	-274	-1,153	251	1,484	-12	1,032
Repayment of Debt	0.00	-16	-168	-30	-717	-3,898	-1,232	-429	506	-351	-187
Issuance of Debt	88	72	767	2,042	971	5,027	701	680	978	339	501
Cash Interest Received	70	98	72	83	51	55	-	45	47	81	-

No quarterly cash flow statements for Fresenius Medical Care are available.

This table presents Fresenius Medical Care's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Total Assets	34,745	37,533	38,250	38,896	38,711	36,961	30,035	28,860	26,830	25,365	25,381
Total Current Assets	6,890	7,986	7,793	9,017	8,888	8,041	8,981	7,657	7,242	6,768	6,718
Cash & Equivalents	1,222	1,553	1,363	1,677	1,321	1,131	2,456	1,175	746	550	634
Accounts Receivable	3,528	4,023	3,974	4,042	3,963	4,018	3,926	4,206	3,893	3,503	3,397
Inventories, net	2,141	2,411	2,456	2,307	2,315	1,867	1,679	1,551	1,407	1,341	1,116
Plant, Property, & Equipment, net	3,774	4,185	4,443	4,793	4,956	4,703	4,390	4,194	3,766	3,426	3,290
Plant, Property & Equipment, gross	3,774	4,185	4,443	4,793	4,956	4,703	4,390	4,194	3,766	-	-
Total Noncurrent Assets	24,081	25,363	26,014	25,086	24,868	24,218	16,663	17,009	15,822	15,171	15,373
Long-Term Investments	643	711	828	891	930	782	744	777	629	645	677
Goodwill	15,703	16,206	16,893	16,254	15,830	15,731	13,974	14,540	13,629	13,033	13,082
Intangible Assets	1,418	1,507	1,625	1,652	1,687	1,601	780	821	845	830	869
Noncurrent Deferred & Refundable Income Taxes	238	314	335	357	429	405	396	379	307	189	141
Other Noncurrent Operating Assets	5,913	6,063	6,334	5,932	5,992	5,698	770	492	412	474	603
Other Noncurrent Nonoperating Assets	167	562	0.00	-	-	-	-	-	-	-	-
Total Liabilities & Shareholders' Equity	34,745	37,533	38,250	38,896	38,711	36,961	30,035	28,860	26,830	25,365	25,381
Total Liabilities	18,423	21,132	21,722	23,075	23,647	22,117	15,268	15,853	15,204	13,841	14,528
Total Current Liabilities	4,424	5,127	5,301	6,553	5,278	5,467	6,019	5,244	4,683	4,149	3,477
Short-Term Debt	2.17	505	694	1,421	97	1,315	1,596	924	605	793	452
Accounts Payable	1,019	979	1,018	971	1,011	937	910	886	883	781	714
Other Current Liabilities	3,403	3,643	3,589	4,161	4,170	3,214	3,324	3,434	3,195	-	-
Total Noncurrent Liabilities	13,999	16,005	16,421	16,521	18,370	16,650	9,249	10,608	10,521	9,691	11,051
Long-Term Debt	7,076	8,238	8,414	8,279	9,539	8,872	7,041	8,022	7,950	7,853	9,014
Capital Lease Obligations	4,286	4,586	5,005	5,375	5,488	5,280	0.00	-	-	-	-
Noncurrent Deferred & Payable Income Tax Liabilities	961	1,086	1,185	1,180	1,201	1,032	717	742	950	625	805
Noncurrent Employee Benefit Liabilities	702	735	550	886	878	773	632	637	539	585	642
Other Noncurrent Operating Liabilities	945	1,160	1,267	801	1,264	692	859	1,207	1,081	466	412
Other Noncurrent Nonoperating Liabilities	28	200	0.00	-	-	-	-	-	-	-	-
Total Equity & Noncontrolling Interests	16,322	16,401	16,528	15,821	15,064	17,175	14,766	13,269	11,626	10,496	10,028
Total Preferred & Common Equity	15,088	15,067	14,966	14,372	13,700	15,751	13,458	12,058	10,496	9,887	9,443
Total Common Equity	15,088	15,067	14,966	14,372	13,700	15,751	13,458	12,058	10,496	10,897	10,453
Common Stock	3,767	4,064	3,922	3,604	3,867	4,390	4,785	5,138	4,489	3,857	3,931
Retained Earnings	11,662	12,082	11,459	12,253	12,527	10,611	10,108	8,574	6,402	7,871	7,105
Accumulated Other Comprehensive Income / (Loss)	-340	-1,079	-416	-1,485	-2,694	1,166	-1,378	-1,785	-341	-1,336	-1,088
Noncontrolling Interest	1,234	1,334	1,562	1,449	1,364	1,425	1,309	1,211	1,129	609	585

No quarterly balance sheets for Fresenius Medical Care are available.

This table displays calculated financial ratios and metrics derived from Fresenius Medical Care's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-6.99%	3.70%	4.07%	-8.60%	11.23%	3.57%	-11.35%	22.55%	3.80%	4.08%	8.32%
EBITDA Growth	1.68%	2.90%	-16.28%	-7.17%	19.26%	-11.73%	17.71%	34.76%	-8.47%	2.14%	1.70%
EBIT Growth	11.23%	8.20%	-33.80%	0.55%	16.89%	-40.21%	22.51%	40.25%	-12.51%	2.58%	-0.07%
NOPAT Growth	-5.94%	5.54%	-37.40%	-22.11%	4.83%	-0.75%	-5.43%	20.59%	13.08%	0.97%	0.49%
Net Income Growth	-5.35%	-15.31%	-30.66%	-21.34%	8.65%	-36.62%	36.41%	25.00%	13.57%	4.41%	0.33%
EPS Growth	0.73%	-23.57%	-25.66%	-16.41%	0.00%	-38.60%	55.05%	11.53%	19.17%	0.00%	0.00%
Operating Cash Flow Growth	-0.20%	5.52%	-15.13%	-53.38%	37.53%	60.45%	-15.58%	-1.27%	4.53%	45.51%	-8.52%
Free Cash Flow Firm Growth	0.57%	169.58%	-27.22%	-51.66%	141.10%	-443.88%	94.90%	-52.03%	21.55%	701.26%	-125.55%
Invested Capital Growth	-5.25%	-4.73%	0.43%	1.41%	-1.63%	40.56%	1.01%	6.36%	-0.90%	-0.17%	10.49%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	24.60%	25.32%	21.37%	27.09%	31.01%	30.87%	31.15%	33.84%	33.89%	33.50%	30.96%
EBITDA Margin	18.74%	17.14%	17.27%	21.47%	21.14%	19.71%	23.13%	17.42%	15.84%	17.97%	18.31%
Operating Margin	7.20%	7.04%	6.69%	10.51%	12.90%	12.99%	13.03%	12.76%	14.54%	13.59%	13.97%
EBIT Margin	9.72%	8.13%	7.79%	12.25%	11.14%	10.60%	18.36%	13.28%	11.61%	13.77%	13.97%
Profit (Net Income) Margin	3.83%	3.77%	4.61%	6.92%	8.04%	8.23%	13.45%	8.74%	8.57%	7.83%	7.81%
Tax Burden Percent	70.10%	70.90%	73.35%	77.55%	74.15%	78.17%	81.33%	77.82%	69.42%	68.18%	68.34%
Interest Burden Percent	56.21%	65.31%	80.65%	72.82%	97.36%	99.35%	90.09%	84.56%	106.34%	83.42%	81.76%
Effective Tax Rate	29.90%	29.10%	26.65%	22.45%	25.85%	21.83%	18.67%	22.18%	30.58%	31.82%	31.66%
Return on Invested Capital (ROIC)	3.83%	3.87%	3.58%	5.78%	7.41%	8.19%	9.98%	10.93%	9.31%	8.19%	8.51%
ROIC Less NNEP Spread (ROIC-NNEP)	1.40%	1.53%	3.09%	3.84%	4.64%	3.67%	18.87%	7.28%	5.92%	5.44%	5.01%
Return on Net Nonoperating Assets (RNNOA)	0.86%	1.05%	2.33%	3.16%	3.47%	1.91%	8.19%	4.07%	4.19%	4.63%	3.99%
Return on Equity (ROE)	4.69%	4.92%	5.92%	8.93%	10.88%	10.11%	18.17%	15.00%	13.51%	12.82%	12.50%
Cash Return on Invested Capital (CROIC)	9.22%	8.71%	3.16%	4.38%	9.05%	-25.53%	8.97%	4.77%	10.22%	8.36%	-1.46%
Operating Return on Assets (OROA)	5.39%	4.62%	4.19%	6.30%	6.42%	6.21%	11.81%	10.19%	7.75%	9.11%	9.30%
Return on Assets (ROA)	2.12%	2.14%	2.48%	3.56%	4.64%	4.82%	8.65%	6.71%	5.72%	5.18%	5.20%
Return on Common Equity (ROCE)	4.32%	4.49%	5.36%	8.12%	9.94%	9.24%	16.54%	13.59%	13.06%	13.33%	12.83%
Return on Equity Simple (ROE_SIMPLE)	5.08%	5.38%	6.39%	9.60%	12.80%	10.25%	18.93%	15.49%	14.23%	13.30%	13.34%
Net Operating Profit after Tax (NOPAT)	1,010	1,074	1,018	1,626	2,087	1,991	2,006	2,122	1,759	1,556	1,541
NOPAT Margin	5.05%	4.99%	4.90%	8.15%	9.57%	10.15%	10.59%	9.93%	10.09%	9.26%	9.55%
Net Nonoperating Expense Percent (NNEP)	2.43%	2.33%	0.50%	1.94%	2.77%	4.52%	-8.89%	3.65%	3.39%	2.75%	3.50%
Return On Investment Capital (ROIC_SIMPLE)	3.65%	3.61%	3.32%	-	-	-	-	-	-	-	-
Cost of Revenue to Revenue	75.40%	74.68%	78.63%	72.91%	68.99%	69.13%	68.85%	66.16%	66.11%	66.50%	67.16%
SG&A Expenses to Revenue	21.08%	20.36%	16.34%	19.07%	17.55%	17.35%	17.44%	20.46%	18.91%	19.08%	16.39%
R&D to Revenue	0.95%	1.19%	1.18%	1.25%	1.09%	0.96%	0.69%	0.62%	0.88%	0.83%	0.76%
Operating Expenses to Revenue	22.03%	21.55%	14.69%	20.32%	18.63%	18.31%	18.13%	21.08%	19.79%	19.91%	17.30%
Earnings before Interest and Taxes (EBIT)	1,946	1,750	1,617	2,443	2,430	2,079	3,477	2,838	2,023	2,313	2,255
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	3,750	3,688	3,584	4,281	4,611	3,867	4,380	3,721	2,761	3,017	2,954
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.44	0.39	0.30	0.61	0.82	0.64	0.65	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.33	0.28	0.22	0.44	0.51	0.51	0.46	0.00	0.00	0.00	0.00
Price to Earnings (P/E)	11.93	10.76	6.29	8.01	7.90	7.48	3.83	0.00	0.00	0.00	0.00
Dividend Yield	2.84%	2.99%	9.87%	5.12%	1.90%	1.99%	2.19%	1.17%	1.25%	1.22%	1.69%
Earnings Yield	8.38%	9.29%	15.89%	12.49%	12.66%	13.37%	26.09%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.68	0.68	0.63	0.80	0.91	0.88	0.76	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.87	0.85	0.87	1.14	1.17	1.28	0.82	0.00	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	4.63	4.97	5.03	5.31	5.52	6.48	3.53	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	8.93	10.48	11.14	9.31	10.48	12.05	4.44	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	17.20	17.07	17.70	13.99	12.20	12.58	7.70	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	8.01	8.44	8.75	9.37	4.89	6.61	6.54	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	7.14	7.58	20.08	18.45	9.99	0.00	8.56	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.70	0.81	0.85	0.95	1.00	0.90	0.58	0.67	0.74	0.82	0.94
Long-Term Debt to Equity	0.70	0.78	0.81	0.86	1.00	0.82	0.48	0.60	0.68	0.75	0.90
Financial Leverage	0.61	0.69	0.76	0.82	0.75	0.52	0.43	0.56	0.71	0.85	0.80
Leverage Ratio	2.21	2.30	2.38	2.51	2.35	2.10	2.10	2.24	2.36	2.47	2.41
Compound Leverage Factor	1.24	1.50	1.92	1.83	2.29	2.08	1.89	1.89	2.51	2.06	1.97
Debt to Total Capital	41.05%	44.84%	46.06%	48.79%	50.10%	47.38%	36.90%	40.27%	42.39%	45.17%	48.56%
Short-Term Debt to Total Capital	0.01%	1.70%	2.27%	4.60%	0.32%	4.03%	6.82%	4.16%	3.00%	4.14%	2.32%
Long-Term Debt to Total Capital	41.04%	43.14%	43.80%	44.19%	49.78%	43.36%	30.09%	36.11%	39.39%	41.03%	46.24%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	4.46%	4.49%	5.10%	4.69%	4.52%	4.36%	5.59%	5.45%	5.60%	3.18%	3.00%
Common Equity to Total Capital	54.50%	50.68%	48.84%	46.52%	45.38%	48.25%	57.50%	54.28%	52.01%	56.93%	53.62%
Debt to EBITDA	3.03	3.61	3.94	3.52	3.28	4.00	1.97	2.40	3.10	2.87	3.20
Net Debt to EBITDA	2.53	3.00	3.33	2.92	2.79	3.51	1.24	1.88	2.60	2.47	2.76
Long-Term Debt to EBITDA	3.03	3.48	3.74	3.19	3.26	3.66	1.61	2.16	2.88	2.60	3.05
Debt to NOPAT	11.25	12.41	13.87	9.27	7.25	7.77	4.30	4.22	4.86	5.56	6.14
Net Debt to NOPAT	9.40	10.30	11.72	7.69	6.17	6.81	2.71	3.30	4.08	4.79	5.29
Long-Term Debt to NOPAT	11.25	11.94	13.19	8.40	7.20	7.11	3.51	3.78	4.52	5.05	5.85
Altman Z-Score	1.53	1.44	1.30	1.47	1.62	1.47	1.94	0.00	0.00	0.00	0.00
Noncontrolling Interest Sharing Ratio	7.85%	8.79%	9.31%	9.11%	8.65%	8.56%	8.99%	9.40%	3.29%	-4.03%	-2.66%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.56	1.56	1.47	1.38	1.68	1.47	1.49	1.46	1.55	1.63	1.93
Quick Ratio	1.07	1.09	1.01	0.87	1.00	0.94	1.06	1.03	0.99	0.98	1.16
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	2,432	2,419	897	1,233	2,550	-6,204	1,804	926	1,930	1,588	-264
Operating Cash Flow to CapEx	299.72%	287.08%	266.01%	251.06%	405.22%	303.07%	0.00%	0.00%	0.00%	0.00%	202.34%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	2.33	0.00	0.00	0.00	3.51	1.85	0.00	3.19	-0.53
Operating Cash Flow to Interest Expense	0.00	0.00	5.35	0.00	0.00	0.00	4.60	5.59	0.00	5.44	3.76
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	3.34	0.00	0.00	0.00	4.72	5.59	0.00	5.44	1.90
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.55	0.57	0.54	0.51	0.58	0.59	0.64	0.77	0.67	0.66	0.67
Accounts Receivable Turnover	5.30	5.38	5.18	4.98	5.47	4.94	4.66	5.28	4.71	4.87	4.90
Inventory Turnover	6.63	6.60	6.85	6.29	7.20	7.65	8.08	9.56	8.39	9.09	9.79
Fixed Asset Turnover	5.03	4.99	4.49	4.09	4.52	4.31	4.41	5.37	4.85	5.00	5.06
Accounts Payable Turnover	15.11	16.09	16.41	14.68	15.45	14.68	14.52	15.97	13.85	14.94	15.70
Days Sales Outstanding (DSO)	68.85	67.81	70.49	73.27	66.77	73.92	78.36	69.19	77.44	74.99	74.51
Days Inventory Outstanding (DIO)	55.04	55.27	53.28	58.02	50.70	47.72	45.20	38.19	43.52	40.14	37.27
Days Payable Outstanding (DPO)	24.16	22.68	22.24	24.87	23.62	24.87	25.14	22.85	26.36	24.43	23.25
Cash Conversion Cycle (CCC)	99.72	100.40	101.53	106.42	93.85	96.78	98.42	84.53	94.60	90.71	88.53
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	25,684	27,106	28,450	28,330	27,936	28,399	20,204	20,002	18,806	18,976	19,008
Invested Capital Turnover	0.76	0.77	0.73	0.71	0.77	0.81	0.94	1.10	0.92	0.88	0.89
Increase / (Decrease) in Invested Capital	-1,422	-1,344	121	393	-462	8,195	202	1,196	-171	-32	1,805
Enterprise Value (EV)	17,377	18,339	18,018	22,744	25,467	25,046	15,442	0.00	0.00	0.00	0.00
Market Capitalization	6,643	5,939	4,534	8,786	11,231	10,067	8,696	0.00	0.00	0.00	0.00
Book Value per Share	$51.42	$51.35	$51.08	$49.05	$45.92	$51.33	$43.91	$39.35	$34.28	$35.69	$34.11
Tangible Book Value per Share	($6.93)	($9.02)	($12.12)	($12.06)	($12.79)	($5.15)	($4.23)	($10.78)	($12.99)	($9.71)	($11.42)
Total Capital	27,686	29,731	30,641	30,897	30,187	32,643	23,403	22,216	20,181	19,142	19,494
Total Debt	11,364	13,330	14,113	15,076	15,123	15,467	8,637	8,946	8,555	8,646	9,466
Total Long-Term Debt	11,362	12,825	13,419	13,654	15,027	14,152	7,041	8,022	7,950	7,853	9,014
Net Debt	9,500	11,066	11,923	12,508	12,872	13,554	5,437	6,994	7,180	7,452	8,155
Capital Expenditures (CapEx)	724	757	775	967	1,285	1,249	-62	0.00	0.00	0.00	920
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,247	1,811	1,823	2,208	2,385	2,758	2,102	2,162	2,418	2,862	3,059
Debt-free Net Working Capital (DFNWC)	2,468	3,364	3,185	3,885	3,707	3,889	4,557	3,337	3,164	3,412	3,693
Net Working Capital (NWC)	2,466	2,859	2,491	2,464	3,610	2,574	2,962	2,413	2,559	2,619	3,241
Net Nonoperating Expense (NNE)	243	264	61	246	333	377	-541	254	265	240	281
Net Nonoperating Obligations (NNO)	9,362	10,705	11,923	12,508	12,872	11,223	5,437	6,733	7,180	8,480	8,980
Total Depreciation and Amortization (D&A)	1,803	1,938	1,967	1,838	2,182	1,788	904	883	738	704	699
Debt-free, Cash-free Net Working Capital to Revenue	6.23%	8.42%	8.78%	11.07%	10.93%	14.06%	11.10%	10.12%	13.87%	17.04%	18.96%
Debt-free Net Working Capital to Revenue	12.33%	15.63%	15.35%	19.48%	16.99%	19.83%	24.06%	15.62%	18.15%	20.32%	22.89%
Net Working Capital to Revenue	12.32%	13.28%	12.01%	12.36%	16.55%	13.13%	15.64%	11.29%	14.68%	15.60%	20.09%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.89	$1.70	$2.30	$3.31	$0.00	$3.96	$6.47	$4.17	$4.07	$3.38	$3.46
Adjusted Weighted Average Basic Shares Outstanding	293.41M	293.41M	293.41M	293.00M	0.00	298.33M	306.88M	306.45M	306.22M	305.31M	303.56M
Adjusted Diluted Earnings per Share	$1.89	$1.70	$2.30	$3.31	$0.00	$3.96	$6.45	$4.16	$0.00	$0.00	$3.45
Adjusted Weighted Average Diluted Shares Outstanding	293.41M	293.41M	293.41M	293.00M	0.00	298.33M	306.88M	306.45M	306.22M	305.31M	303.56M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	293.41M	293.41M	293.41M	293.00M	0.00	298.33M	306.88M	306.45M	306.22M	305.31M	303.56M
Normalized Net Operating Profit after Tax (NOPAT)	1,010	1,074	1,018	1,626	2,087	1,991	2,006	2,122	1,759	1,556	1,541
Normalized NOPAT Margin	5.05%	4.99%	4.90%	8.15%	9.57%	10.15%	10.59%	9.93%	10.09%	9.26%	9.55%
Pre Tax Income Margin	5.47%	5.31%	6.29%	8.92%	10.84%	10.53%	16.54%	11.23%	12.34%	11.49%	11.43%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	4.20	0.00	0.00	0.00	6.77	5.68	0.00	4.65	4.55
NOPAT to Interest Expense	0.00	0.00	2.64	0.00	0.00	0.00	3.91	4.24	0.00	3.13	3.11
EBIT Less CapEx to Interest Expense	0.00	0.00	2.19	0.00	0.00	0.00	6.90	5.68	0.00	4.65	2.69
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.63	0.00	0.00	0.00	4.03	4.24	0.00	3.13	1.25
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	45.24%	14.60%	0.00%	0.00%	0.00%	-45.10%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	86.94%	16.27%	0.00%	0.00%	0.00%	-45.10%

No quarterly metrics and ratios for Fresenius Medical Care are available.

Frequently Asked Questions About Fresenius Medical Care's Financials

When does Fresenius Medical Care's fiscal year end?

According to the most recent income statement we have on file, Fresenius Medical Care's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Fresenius Medical Care's net income changed over the last 10 years?

Fresenius Medical Care's net income appears to be on a downward trend, with a most recent value of $766.87 million in 2024, falling from $1.26 billion in 2014. The previous period was $810.25 million in 2023. View Fresenius Medical Care's forecast to see where analysts expect Fresenius Medical Care to go next.

What is Fresenius Medical Care's operating income?

Fresenius Medical Care's total operating income in 2024 was $1.44 billion, based on the following breakdown:

Total Gross Profit: $4.92 billion
Total Operating Expenses: $4.41 billion

How has Fresenius Medical Care revenue changed over the last 10 years?

Over the last 10 years, Fresenius Medical Care's total revenue changed from $16.13 billion in 2014 to $20.01 billion in 2024, a change of 24.1%.

How much debt does Fresenius Medical Care have?

Fresenius Medical Care's total liabilities were at $18.42 billion at the end of 2024, a 12.8% decrease from 2023, and a 26.8% increase since 2014.

How much cash does Fresenius Medical Care have?

In the past 10 years, Fresenius Medical Care's cash and equivalents has ranged from $549.50 million in 2015 to $2.46 billion in 2018, and is currently $1.22 billion as of their latest financial filing in 2024.

How has Fresenius Medical Care's book value per share changed over the last 10 years?

Over the last 10 years, Fresenius Medical Care's book value per share changed from 34.11 in 2014 to 51.42 in 2024, a change of 50.8%.

Related Companies

This page (NYSE:FMS) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Fresenius Medical Care (FMS) Financials

Frequently Asked Questions About Fresenius Medical Care's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Fresenius Medical Care (FMS) Financials

Annual Income Statements for Fresenius Medical Care

Quarterly Income Statements for Fresenius Medical Care

Annual Cash Flow Statements for Fresenius Medical Care

Quarterly Cash Flow Statements for Fresenius Medical Care

Annual Balance Sheets for Fresenius Medical Care

Quarterly Balance Sheets for Fresenius Medical Care

Annual Metrics And Ratios for Fresenius Medical Care

Quarterly Metrics And Ratios for Fresenius Medical Care

Frequently Asked Questions About Fresenius Medical Care's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools